What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment
Rieke Alten, Juan Carlos Nieto-Gonzalez, Peggy Jacques, Carlomaurizio Montecucco, Robert Moots, Helga Radner, Harald E Vonkeman, Sebastian Heidenreich, Chiara Whichello, Nicolas Krucien, Katrien Van Beneden
RMD Open Jan 2024, 10 (1) e003311; DOI: 10.1136/rmdopen-2023-003311